Keyphrases
Protease
100%
Apoptosis
100%
HPV16
100%
Early Protein
100%
Mitochondrial Permeability Transition
100%
Atractylodin
100%
Induced Apoptosis
53%
Membrane Permeability Transition
38%
Mitochondria
30%
High-risk Human Papillomavirus (HR-HPV)
30%
3T3 Cells
30%
Mitochondrium
30%
Temperature Sensitivity
15%
HeLa
15%
SiHa
15%
CaSki
15%
C-33A
15%
Cervical Carcinoma Cells
15%
Cell-free
7%
Cell Viability
7%
Cyclosporine
7%
Apoptosis Induction
7%
B-cell Lymphoma 2 (Bcl-2)
7%
Mutant p53
7%
Cervical Cancer
7%
Protease Inhibitors
7%
Dose Effect
7%
Inducer
7%
Sensitive Mechanism
7%
DNA Laddering
7%
Cell Carcinoma
7%
Cell Cycle Arrest
7%
Proteolysis
7%
Tumor Protein p53 (TP53)
7%
Nuclear DNA (nDNA)
7%
Wild-type p53
7%
Apoptosis-inducing Activity
7%
Focus of Attention
7%
P53 Expression
7%
Nuclear Fragmentation
7%
Cervical Epithelial Cells
7%
Cell Temperature
7%
C33A Cells
7%
Free Model
7%
Epithelial Transformation
7%
Normal Temperature
7%
Protease Sensitive
7%
Human Papillomavirus Genotypes
7%
Biochemistry, Genetics and Molecular Biology
Early Protein
100%
Proteases
100%
Mitochondrial Permeability
100%
Human Papillomavirus Type 16
100%
P53
100%
Programmed Cell Death
100%
Membrane Permeability
31%
Mitochondrion
25%
Sensitization
25%
Wart Virus
18%
Protease Inhibitor
6%
Cell Viability
6%
DNA Laddering
6%
Bcl-2
6%
Cell Cycle Arrest
6%
Mitochondrial Membrane
6%
Cell Cycle Checkpoint
6%
Human Papillomavirus Type 18
6%
Ciclosporin
6%
Outer Mitochondrial Membrane
6%
Protease
6%
Proteolysis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Human Papillomavirus Type 16
100%
Atractyloside
100%
Human Papillomavirus
25%
Uterine Cervix Carcinoma
16%
Cell Viability
8%
Infection
8%
Ciclosporin
8%
Proteinase
8%
Uterine Cervix Cancer
8%
Proteinase Inhibitor
8%
DNA Laddering
8%
Human Papillomavirus Type 18
8%